Molecular Clocks in Translational Roadmap for Circadian‐Based Therapeutics in Lung Diseases
The FASEB Journal · 31.05.2026 · 40 (10)
DOI: 10.1096/fj.202504876r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 26.05.2026. Verfasst von Kingshuk Panda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA. Hauptthemen laut MEDLINE: Lung Diseases, Circadian Clocks, Circadian Rhythm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NIEHS NIH HHS.
Abstract (Originalsprache)
The lung contains a robust peripheral circadian clock that regulates airway tone, epithelial barrier integrity, immune cell trafficking, and metabolic homeostasis through transcriptional–translational feedback loops involving BMAL1 , CLOCK , PER , CRY , REV‐ERBα , and RORα . Disruption of this molecular clock is increasingly recognized as a central pathogenic mechanism across pulmonary diseases. Inflammatory signaling, cigarette smoke, hyperoxia, infection, and developmental stress suppress core clock components, dampen clock‐controlled gene rhythms, and drive persistent inflammation, impaired mucociliary clearance, oxidative injury, epithelial–mesenchymal transition, fibrosis, and tumor progression. Altered rhythmicity of BMAL1 , REV‐ERBα , PER2 , and RORα has been reported in asthma, COPD, idiopathic pulmonary fibrosis, bronchopulmonary dysplasia, pneumonia, and lung cancer, correlating with characteristic diurnal fluctuations in symptoms and lung function. This narrative review integrates current evidence linking chronodisruption to pulmonary pathobiology and highlights emerging therapeutic strategies aimed at restoring circadian homeostasis. Small‐molecule modulators of REV‐ERBα, RORα, CRY, PER, CLOCK, and metabolic pathways (NAD + –SIRT1 axis), in conjunction with chronotherapy‐based timing of standard treatments, show potential to reestablish rhythmic gene expression and attenuate inflammation and tissue remodeling. The lung circadian clock is a central regulator of respiratory physiology and a promising therapeutic target in chronic lung disease. Strategies that restore rhythmicity, including clock‐directed small molecules and time‐optimized therapies, offer emerging opportunities to reduce inflammation, prevent maladaptive remodeling, and improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
- Environmental Medicine, University of Rochester Medical Center, Rochester, New York, USA.
ORCID-Profile: Hoshang Unwalla
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- NIEHS NIH HHS
Zitieren
APA
Panda, K., Khasa, R., Chinnapaiyan, S., Aggarwal, S., Rahman, I., & Unwalla, H. (2026). Molecular Clocks in Translational Roadmap for Circadian‐Based Therapeutics in Lung Diseases. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202504876r
Vancouver
Panda K, Khasa R, Chinnapaiyan S, Aggarwal S, Rahman I, Unwalla H. Molecular Clocks in Translational Roadmap for Circadian‐Based Therapeutics in Lung Diseases. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202504876r
BibTeX
@article{Panda2026,
author = {Panda, Kingshuk and Khasa, Renu and Chinnapaiyan, Srinivasan and Aggarwal, Saurabh and Rahman, Irfan and Unwalla, Hoshang},
title = {Molecular Clocks in Translational Roadmap for Circadian‐Based Therapeutics in Lung Diseases},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {10},
doi = {10.1096/fj.202504876r}
}
EUVIMED